2 million people join study to see if 'Aging Clock' predicts disease and death
NCT ID NCT07595094
First seen May 31, 2026 · Last updated Jun 17, 2026 · Updated 3 times
Summary
This study looks at whether a measure called Phenotypic Age Acceleration (PhenoAgeAccel), calculated from routine blood tests, can predict who will develop major chronic diseases like diabetes, dementia, cancer, or lung disease, and how long they might live. Researchers will follow 2 million Chinese adults aged 35-73 for years, using their medical records to track new illnesses and deaths. No treatments or extra procedures are involved—just observation and data analysis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENOTYPIC AGE ACCELERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Second Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.